Pharma exec: New type 2 diabetes treatment competitively priced
How the first oral GLP-1 oral treatment for type 2 diabetes is unique and how it will be priced compared to other GLP-1 medications.
Read More
Four Myths You Probably Believe About Social Determinants of Health
SDoH: Myths vs. facts.
Increasing Access to Gene Therapies Requires Innovative Payment Approaches
One key opinion leader calls on healthcare to ensure access to gene therapies.
3 Contract Negotiation Tips for Healthcare Execs
Expert shares the skills healthcare executives need for successful negotiation.
Mayo Clinic, Google to Form Healthcare Partnership
Technology will apply advanced computing techniques to healthcare problems.
Medical Imaging Trends in the U.S.
ICER’s Leader: How to Assess the Value of Cell and Gene Therapies
Payers grapple with expensive treatment payment options.
Overdoses on the rise for this antidiarrheal drug
FDA limits packaging for this OTC medication.
Five Ways Oncology Has Become More Personalized
Cancer treatment is becoming more personalized. Here’s how.
Championing Community Support, Privacy in Cancer Care Facilities
Oncological facilities that promote flexibility are the ones best suited to care for the needs of their patient population.
The Use of Wearables in Health Studies
To take advantage of new devices in health studies, executives need to reinvent how data is put to work.
Innovative Staff Areas––A Critical Component for More Impactful Cancer Care
Optimizing the nursing function is a key design consideration to improve the patient experience and patient-reported outcomes
Why Community Health Workers Are Vital to Addressing SDoH
Tackling SDoH issues requires efforts beyond traditional healthcare roles.
Will Americans Accept Longer Wait Time in Medicare For All?
The Medicare for All debate surrounds the 2020 election-but is it truly understood?
Collaboration Aims to Help Physicians Provide Value-based Care to Californians
Altais, Aledade, and the California Medical Association team up to offer patient care model supported by innovative technologies
Consumer Perceptions of Telehealth
Health execs should consider consumers’ desires as they work to tailor their telehealth programs to ensure healthy adoption rates, and ultimately to drive improved outcomes.
Disrupt or Be Disrupted: Predictive Analytics and Healthcare
Predictive analytics in healthcare powered by artificial intelligence represents one of the most disruptive shifts. Here's how to take advantage of it.
Community-based Care Model Reduces CVD Risk
Intervention of friends, family, and non-physician health workers is key.
Making the Most of Predictive Analytics
Data is only valuable if it’s analyzed correctly. But that’s easier said than done.
Most Older Adults Unprepared for Emergencies, Poll Finds
When disaster strikes, healthcare executives must be ready to take care of those in need of emergency medical services.
Custom Data Collection System to Improve Health Disparity Research
Web-based application has the potential to revolutionize survey research and ultimately improve the health and well-being of many diverse populations.
Can Data Analytics Lower Hospital-Acquired Condition Incidence?
HACs continue to burden the healthcare system.
Better Design to Help Ease a Parent’s Worst Nightmare
Simple design considerations at St. Jude Children's Research Hospital make a positive impact on loved ones.
A New Approach to Health Plan-Provider Collaboration
CareAllies, Arcadia partner to educate healthcare leaders on how health plans can provide actionable insights at the point of care.
How to Prepare for Leadership Changes
How to cope with a rapidly-changing industry.
Generics of Older Drugs Could Have Saved Medicare Billions, Study Says
Findings suggest that racemic substitution for single-enantiomer drugs offers an opportunity for savings.
Manufacturer recalls several compounded drugs over sterility issues
Fentanyl citrate and ephedrine sulfate are among the medications affected.
Starbucks Aims to Improve Mental Health Benefits
The move could be copied by other large employers.
FDA Urges Inclusion of Males in Breast Cancer Studies
Because the disease in males is rare, they have historically been excluded from clinical trials of breast cancer drugs.
Cancer-linked impurity found in heartburn drug
FDA is evaluating risks to patients.
